Skip to content
lifestyle.the-newshub.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
HUTCHMED (China) Limited
HUTCHMED Announces Update on Licensed Oncology Product TAZVERIK® in China
May 21, 2026
Intended Retirement of Independent Non-executive Director and changes of composition of board committees
April 28, 2026
HUTCHMED Reports 2025 Full Year Results and Business Updates
April 28, 2026
HUTCHMED Initiates Global Trial of PI3K/PIKK-EGFR ATTC Candidate HMPL-A580 in Patients with Solid Tumors
April 28, 2026
HUTCHMED to Announce 2025 Final Results
February 12, 2026
←
Previous Page
1
2